ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1-Hydroxybenzotriazole → 1-(6-Chloronaphthalene-2-sulfonyl)-4-(4-diisopropylaminomethyl-2-methoxybenzoyl)piperazine

HRID 278598
印刷

反応式

HRID 278598 の反応式
Cl.[Cl:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[CH:9]=[C:8]([S:13]([N:16]1[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]1)(=[O:15])=[O:14])[CH:7]=[CH:6]2.[CH:22]([N:25]([CH2:29][C:30]1[CH:38]=[CH:37][C:33]([C:34](O)=[O:35])=[C:32]([O:39][CH3:40])[CH:31]=1)[CH:26]([CH3:28])[CH3:27])([CH3:24])[CH3:23].C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl>CN(C=O)C.C(N(CC)CC)C>[Cl:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[CH:9]=[C:8]([S:13]([N:16]1[CH2:17][CH2:18][N:19]([C:34](=[O:35])[C:33]3[CH:37]=[CH:38][C:30]([CH2:29][N:25]([CH:26]([CH3:27])[CH3:28])[CH:22]([CH3:24])[CH3:23])=[CH:31][C:32]=3[O:39][CH3:40])[CH2:20][CH2:21]1)(=[O:14])=[O:15])[CH:7]=[CH:6]2
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 757711-HydroxybenzotriazoleHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 226279874-Diisopropylaminomethyl-2-methoxybenzoic acidHCID 227097661-(6-Chloronaphth-2-ylsulphonyl)piperazine hydrochloride

生成物 1

HCID 226279571-(6-Chloronaphthalene-2-sulfonyl)-4-(4-diisopropylaminomethyl-2-methoxybenzoyl)piperazine
収率 61.6%

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 8471Triethylamine溶媒

実験手順

To a solution of 1-(6-chloronaphthalene-2-sulfonyl)piperazine hydrochloride(100 mg), 4-diisopropylaminomethyl-2-methoxybenzoic acid (77 mg), triethylamine (35 mg) and HOBt (43 mg) in DMF (10 ml) was added WSC hydrochloride (61 mg) under ice-cooling, and the solution was stirred at room temperature for 4 hours and concentrated. To the residue were added ethyl acetate and sodium bicarbonate solution. The organic layer was separated, washed with water and extracted with 1 N hydrochloric acid. The extract was made alkaline with sodium hydroxide solution and extracted with dichloromethane. The extract was dried and concentrated and the residue was crystallized with ether to give colorless crystals of the title compound (99 mg).

後処理

  1. temperaturecooling
  2. concentrationconcentrated
  3. additionTo the residue were added ethyl acetate and sodium bicarbonate solution
  4. customThe organic layer was separated
  5. washwashed with water
  6. extractionextracted with 1 N hydrochloric acid
  7. extractionextracted with dichloromethane
  8. customThe extract was dried
  9. concentrationconcentrated
  10. customthe residue was crystallized with ether

出典と根拠

ORDレコード
ord-5b81db15f67e4df78287ac04b92003ac
出典データセット
uspto-grants-2002_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06359134B1

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート